Two mutations (the c.1114delG allele in the TYR gene and the c.1426A>G allele in the OCA2 gene) may play a role in formation of certain clinical manifestations of OCA in heterozygous carriers. This evidence concerns the gene OCA2 and oculocutaneous albinism.